XML 37 R23.htm IDEA: XBRL DOCUMENT v3.20.2
EARNINGS PER SHARE
6 Months Ended
Jun. 30, 2020
Earnings Per Share [Abstract]  
EARNINGS PER SHARE EARNINGS PER SHARE
We determined that the Series B Preferred Shares are a participating security, and accordingly, our basic and diluted net income / loss per share is calculated using the two-class method. Under the two-class method, basic net income / loss per common share is computed by dividing the net income available to common shareholders after deducting contractual amounts of accretion on our Series B Preferred Shares and the income allocated to these shares by the weighted-average number of common shares outstanding during the period. Diluted net income / loss per share is computed by dividing the adjusted net income by the weighted-average number of dilutive shares outstanding during the period after adjusting for the impact of those dilutive shares on the allocation of income to the Series B Preferred Shares.
The components of basic and diluted earnings per share are as follows:
 
For the Three Months Ended June 30,
 
For the Six Months Ended June 30,
 
2020

 
2019

 
2020

 
2019

Income from operations
$
31,102

 
$
44,078

 
$
40,072

 
$
55,829

Net loss / (income) attributable to noncontrolling interests
77

 
(119
)
 
148

 
(112
)
Less: income allocated to Series B Preferred Shares
(9,197
)
 
(13,003
)
 
(11,873
)
 
(16,490
)
Net income attributable to CME Ltd. available to common shareholders — basic
21,982

 
30,956

 
28,347

 
39,227

 
 
 
 
 
 
 
 
Effect of dilutive securities
 
 
 
 
 
 
 
Dilutive effect of RSUs and employee stock options
27

 
47

 
45

 
54

Net income attributable to CME Ltd. available to common shareholders — diluted
$
22,009

 
$
31,003

 
$
28,392

 
$
39,281

 
 
 
 
 
 
 
 
Weighted average outstanding shares of common stock — basic (1)
265,649

 
264,570

 
265,342

 
264,385

Dilutive effect of employee stock options and RSUs
1,127

 
1,362

 
1,448

 
1,243

Weighted average outstanding shares of common stock — diluted
266,776

 
265,932

 
266,790

 
265,628

 
 
 
 
 
 
 
 
Net income per share:
 
 
 
 
 
 
 
Attributable to CME Ltd. — basic
$
0.08

 
$
0.12

 
$
0.11

 
$
0.15

Attributable to CME Ltd. — diluted
0.08

 
0.12

 
0.11

 
0.15

(1) 
For the purpose of computing basic earnings per share, the 11,211,449 shares of Class A common stock underlying the Series A Preferred Share are included in the weighted average outstanding shares of common stock - basic, because the rights of the Series A Preferred Share are considered substantially similar to that of our Class A common stock.
Weighted-average equity awards and convertible shares are excluded from the calculation of diluted earnings per share if their effect would be anti-dilutive. The following instruments were anti-dilutive for the periods presented but may be dilutive in future periods:
 
For the Three Months Ended June 30,
 
For the Six Months Ended June 30,
 
2020

 
2019

 
2020

 
2019

RSUs
836

 
1,233

 
836

 
1,233

Total
836

 
1,233

 
836

 
1,233